Table of Contents
International Journal of Molecular Imaging
Volume 2011 (2011), Article ID 537687, 7 pages
http://dx.doi.org/10.1155/2011/537687
Review Article

Advances in Drug Design of Radiometal-Based Imaging Agents for Bone Disorders

1Division of Pharmaceutical Sciences, Graduate School of Natural Science and Technology, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan
2Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan

Received 5 August 2011; Accepted 26 September 2011

Academic Editor: Habib Zaidi

Copyright © 2011 Kazuma Ogawa and Hideo Saji. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. E. Coleman, “Skeletal complications of malignancy,” Cancer, vol. 80, no. 8, pp. 1588–1594, 1997. View at Google Scholar · View at Scopus
  2. A. Z. Krasnow, R. S. Hellman, M. E. Timins, B. D. Collier, T. Anderson, and A. T. Isitman, “Diagnostic bone scanning in oncology,” Seminars in Nuclear Medicine, vol. 27, no. 2, pp. 107–141, 1997. View at Google Scholar · View at Scopus
  3. G. Subramanian and J. G. McAfee, “A new complex of 99mTc for skeletal imaging,” Radiology, vol. 99, no. 1, pp. 192–196, 1971. View at Google Scholar · View at Scopus
  4. G. Subramanian, J. G. McAfee, E. G. Bell, R. J. Blair, R. E. O'Mara, and P. H. Ralston, “99mTc-labeled polyphosphate as a skeletal imaging agent,” Radiology, vol. 102, no. 3, pp. 701–704, 1972. View at Google Scholar · View at Scopus
  5. J. W. Fletcher, E. Solaric George, R. E. Henry, and R. M. Donati, “Evaluation of 99mTc pyrophosphate as a bone imaging agent,” Radiology, vol. 109, no. 2, pp. 467–469, 1973. View at Google Scholar · View at Scopus
  6. G. Subramanian, J. G. McAfee, R. J. Blair, A. Mehter, and T. Connor, “99mTc-EHDP: a potential radiopharmaceutical for skeletal imaging,” Journal of Nuclear Medicine, vol. 13, no. 12, pp. 947–950, 1972. View at Google Scholar · View at Scopus
  7. F. P. Castronovo and R. J. Callahan, “New bone scanning agent: 99mTc-labeled 1-hydroxy-ethylidene-1, 1-disodium phosphonate,” Journal of Nuclear Medicine, vol. 13, no. 11, pp. 823–827, 1972. View at Google Scholar · View at Scopus
  8. Y. Yano, J. McRae, D. C. Van Dyke, and H. O. Anger, “Technetium-99m-labeled stannous ethane-1-hydroxy-1 1-diphosphonate: a new bone scanning agent,” Journal of Nuclear Medicine, vol. 14, no. 2, pp. 73–78, 1973. View at Google Scholar · View at Scopus
  9. M. Larsen, R. Willett, and R. G. Yount, “Imidodiphosphate and pyrophosphate: possible biological significance of similar structures,” Science, vol. 166, no. 3912, pp. 1510–1511, 1969. View at Google Scholar · View at Scopus
  10. D. L. Citrin, R. G. Bessent, J. B. Tuohy et al., “A comparison of phosphate bone-scanning agents in normal subjects and patients with malignant disease,” The British Journal of Radiology, vol. 48, pp. 118–121, 1975. View at Google Scholar
  11. G. Subramanian, J. G. McAfee, and R. J. Blair, “Technetium 99m methylene diphosphonate: a superior agent for skeletal imaging: comparison with other technetium complexes,” Journal of Nuclear Medicine, vol. 16, no. 8, pp. 744–755, 1975. View at Google Scholar · View at Scopus
  12. J. A. Bevan, A. J. Tofe, and J. J. Benedict, “Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals,” Journal of Nuclear Medicine, vol. 21, no. 10, pp. 961–966, 1980. View at Google Scholar · View at Scopus
  13. P. A. Domstad, J. J. Coupal, E. E. Kim, J. S. Blake, and F. H. DeLand, “99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content,” Radiology, vol. 136, pp. 209–211, 1980. View at Google Scholar
  14. C. Mari, A. Catafau, and I. Carrio, “Bone scintigraphy and metabolic disorders,” Quarterly Journal of Nuclear Medicine, vol. 43, no. 3, pp. 259–267, 1999. View at Google Scholar · View at Scopus
  15. C. Love, A. S. Din, M. B. Tomas, T. P. Kalapparambath, and C. J. Palestro, “Radionuclide bone imaging: an illustrative review,” Radiographics, vol. 23, no. 2, pp. 341–358, 2003. View at Google Scholar · View at Scopus
  16. S. S. Jurisson, J. J. Benedict, R. C. Elder, R. Whittle, and E. Deutsch, “Calcium affinity of coordinated diphosphonate ligands. Single-crystal structure of [(en)2Co(O2P(OH)CH2P(OH)O2)]ClO4 · H2O. Implications for the chemistry of technetium-99m-diphosphonate skeletal imaging agents,” Inorganic Chemistry, vol. 22, no. 9, pp. 1332–1338, 1983. View at Google Scholar · View at Scopus
  17. M. D. Francis, D. L. Ferguson, and A. J. Tofe, “Comparative evaluation of three diphosphonates: in vitro adsorption (C-14 labeled) and in vivo osteogenic uptake (Tc-99m complexed),” Journal of Nuclear Medicine, vol. 21, no. 12, pp. 1185–1189, 1980. View at Google Scholar · View at Scopus
  18. J. P. Lavender, R. A. A. Khan, and S. P. F. Hughes, “Blood flow and tracer uptake in normal and abnormal canine bone: comparisons with Sr-85 microspheres, Kr-81m, and Tc-99m MDP,” Journal of Nuclear Medicine, vol. 20, no. 5, pp. 413–418, 1979. View at Google Scholar · View at Scopus
  19. R. S. Budd, G. S. Hodgson, and W. S. C. Hare, “The relation of radionuclide uptake by bone to the rate of calcium mineralization. I: experimental studies using 45Ca, 32P and 99Tcm-MDP,” British Journal of Radiology, vol. 62, no. 736, pp. 314–317, 1989. View at Google Scholar · View at Scopus
  20. R. S. Budd, G. S. Hodgson, and W. S. C. Hare, “The relation of radionuclide uptake by bone to the rate of calcium mineralization. II: patient studies using 99Tcm-MDP,” British Journal of Radiology, vol. 62, no. 736, pp. 318–320, 1989. View at Google Scholar · View at Scopus
  21. D. Kanishi, “99mTc-MDP accumulation mechanisms in bone,” Oral Surgery Oral Medicine and Oral Pathology, vol. 75, no. 2, pp. 239–246, 1993. View at Google Scholar · View at Scopus
  22. C. S. B. Galasko, “Mechanism of uptake of bone imaging isotopes by skeletal metastases,” Clinical Nuclear Medicine, vol. 5, no. 12, pp. 565–568, 1980. View at Google Scholar · View at Scopus
  23. S. Tanabe, J. P. Zodda, and E. Deutsch, “Effect of pH on the formation of Tc(NaBH4)-MDP radiopharmaceutical analogues,” International Journal of Applied Radiation and Isotopes, vol. 34, no. 12, pp. 1577–1584, 1983. View at Publisher · View at Google Scholar · View at Scopus
  24. G. M. Wilson and T. C. Pinkerton, “Determination of charge and size of technetium diphosphonate complexes by anion-exchange liquid chromatography,” Analytical Chemistry, vol. 57, no. 1, pp. 246–253, 1985. View at Google Scholar · View at Scopus
  25. T. C. Pinkerton, K. T. Cheng, S. M. Shaw, and G. M. Wilson, “Influence of complex charge and size on the uptake of 99mTc-diphosphonates in osteogenic tissue,” International Journal of Radiation Applications and Instrumentation, vol. 13, no. 1, pp. 49–56, 1986. View at Google Scholar · View at Scopus
  26. J. L. Meyer and G. H. Nancollas, “The influence of multidentate organic phosphonates on the crystal growth of hydroxyapatite,” Calcified Tissue International, vol. 13, no. 4, pp. 295–303, 1973. View at Google Scholar · View at Scopus
  27. K. Libson, E. Deutsch, and B. L. Barnett, “Structural characterization of a 99Tc-diphosphonate complex. Implications for the chemistry of 99mTc skeletal imaging agents,” Journal of the American Chemical Society, vol. 102, no. 7, pp. 2476–2478, 1980. View at Google Scholar · View at Scopus
  28. K. Verbeke, J. Rozenski, B. Cleynhens et al., “Development of a conjugate of 99mTc-EC with aminomethylenediphosphonate in the search for a bone tracer with fast clearance from soft tissue,” Bioconjugate Chemistry, vol. 13, no. 1, pp. 16–22, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Ogawa, T. Mukai, Y. Inoue, M. Ono, and H. Saji, “Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent,” Journal of Nuclear Medicine, vol. 47, no. 12, pp. 2042–2047, 2006. View at Google Scholar · View at Scopus
  30. E. Palma, B. L. Oliveira, J. D. G. Correia et al., “A new bisphosphonate-containing 99mTc(I) tricarbonyl complex potentially useful as bone-seeking agent: synthesis and biological evaluation,” Journal of Biological Inorganic Chemistry, vol. 12, no. 5, pp. 667–679, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. R. Torres Martin De Rosales, C. Finucane, S. J. Mather, and P. J. Blower, “Bifunctional bisphosphonate complexes for the diagnosis and therapy of bone metastases,” Chemical Communications, no. 32, pp. 4847–4849, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. K. P. Zhernosekov, D. V. Filosofov, R. P. Baum et al., “Processing of generator-produced 68Ga for medical application,” Journal of Nuclear Medicine, vol. 48, no. 10, pp. 1741–1748, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. R. T. Goulet, A. Shysh, A. A. Noujaim, and B. C. Lentle, “Investigation of 68Ga tripolyphosphate as a potential bone scanning agent,” International Journal of Applied Radiation and Isotopes, vol. 26, no. 4, pp. 195–199, 1975. View at Publisher · View at Google Scholar · View at Scopus
  34. M. K. Dewanjee, D. J. Hnatowich, and R. Beh, “New 68Ga labeled skeletal imaging agents for positron scintigraphy,” Journal of Nuclear Medicine, vol. 17, no. 11, pp. 1003–1007, 1976. View at Google Scholar · View at Scopus
  35. M. Mitterhauser, S. Toegel, W. Wadsak et al., “Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMP,” Nuclear Medicine and Biology, vol. 34, no. 4, pp. 391–397, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. M. Fellner, R. P. Baum, V. Kubíček et al., “PET/CT imaging of osteoblastic bone metastases with 68Ga- bisphosphonates: first human study,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 4, p. 834, 2010. View at Publisher · View at Google Scholar · View at PubMed
  37. K. Ogawa, K. Takai, H. Kanbara et al., “Preparation and evaluation of a radiogallium complex-conjugated bisphosphonate as a bone scintigraphy agent,” Nuclear Medicine and Biology, vol. 38, no. 5, pp. 631–636, 2011. View at Publisher · View at Google Scholar · View at PubMed
  38. M. Blau, W. Nagler, and M. A. Bender, “Fluorine-18: a new isotope for bone scanning,” Journal of Nuclear Medicine, vol. 3, pp. 332–334, 1962. View at Google Scholar
  39. A. G. Jones, M. D. Francis, and M. A. Davis, “Bone scanning: radionuclidic reaction mechanisms,” Seminars in Nuclear Medicine, vol. 6, no. 1, pp. 3–18, 1976. View at Google Scholar · View at Scopus
  40. S. Bang and C. A. Baud, “Topographical distribution of fluoride in iliac bone of a fluoride-treated osteoporotic patient,” Journal of Bone and Mineral Research, vol. 5, no. 1, pp. S87–S89, 1990. View at Google Scholar · View at Scopus
  41. G. M. Blake, S. J. Park-Holohan, G. J. R. Cook, and I. Fogelman, “Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate,” Seminars in Nuclear Medicine, vol. 31, no. 1, pp. 28–49, 2001. View at Google Scholar · View at Scopus
  42. H. Schirrmeister, A. Guhlmann, K. Elsner et al., “Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET,” Journal of Nuclear Medicine, vol. 40, no. 10, pp. 1623–1629, 1999. View at Google Scholar · View at Scopus
  43. H. Schirrmeister, A. Guhlmann, J. Kotzerke et al., “Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography,” Journal of Clinical Oncology, vol. 17, no. 8, pp. 2381–2389, 1999. View at Google Scholar